ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

被引：360

作者：

Cardoso, F. ^{[1
,2
,3
]}

Costa, A. ^{[4
,5
]}

Norton, L. ^{[6
]}

Senkus, E. ^{[7
]}

Aapro, M. ^{[8
]}

Andre, F. ^{[9
]}

Barrios, C. H. ^{[10
]}

Bergh, J. ^{[11
,12
,13
]}

Biganzoli, L. ^{[14
]}

Blackwell, K. L. ^{[15
]}

Cardoso, M. J. ^{[16
]}

Cufer, T. ^{[17
]}

El Saghir, N. ^{[18
]}

Fallowfield, L. ^{[19
]}

Fenech, D. ^{[20
]}

Francis, P. ^{[21
]}

Gelmon, K. ^{[22
]}

Giordano, S. H. ^{[23
,24
]}

Gligorov, J. ^{[25
]}

Goldhirsch, A. ^{[26
]}

Harbeck, N. ^{[27
]}

Houssami, N. ^{[28
]}

Hudis, C. ^{[29
]}

Kaufman, B. ^{[30
]}

Krop, I. ^{[31
]}

Kyriakides, S. ^{[32
]}

Lin, U. N. ^{[31
]}

Mayer, M. ^{[33
]}

Merjaver, S. D. ^{[34
,35
]}

Nordstrom, E. B. ^{[36
]}

Pagani, O. ^{[37
,38
]}

Partridge, A. ^{[39
]}

Penault-Llorca, F. ^{[40
]}

Piccart, M. J. ^{[41
]}

Rugo, H. ^{[42
]}

Sledge, G. ^{[43
]}

Thomssen, C. ^{[44
]}

van't Veer, L. ^{[45
]}

Vorobiof, D. ^{[46
]}

Vrieling, C. ^{[47
]}

West, N. ^{[48
,49
]}

Xu, B. ^{[48
,49
]}

Winer, E. ^{[31
]}

机构：

[1] Champalimaud Canc Ctr, Av. Brasilia S-N, P-1400048 Lisbon, Portugal

[2] Champalimaud Canc Ctr, European Sch Oncol, Lisbon, Portugal

[3] Champalimaud Canc Ctr, Breast Unit, Lisbon, Portugal

[4] European Sch Oncol, Milan, Italy

[5] European Sch Oncol, Bellinzona, Switzerland

[6] Mem Sloan Kettering Canc Ctr, Breast Canc Program, New York, NY 10021 USA

[7] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[8] Inst Multidisciplinaire Oncol, Div Oncol, Genolier, Switzerland

[9] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[10] PUCRS Sch Med, Dept Med, Porto Alegre, RS, Brazil

[11] Karolinska Inst, Dept Oncol, Radiumhemmet, Stockholm, Sweden

[12] Canc Ctr Karolinska, Stockholm, Sweden

[13] Karolinska Univ Hosp, Stockholm, Sweden

[14] Sandro Pitigliani Oncol Ctr, Dept Med Oncol, Prato, Italy

[15] Duke Canc Inst, Breast Canc Clin Program, Durham, NC USA

[16] Champalimaud Canc Ctr, Breast Unit, Lisbon, Portugal

[17] Univ Clin Golnik, Med Fac Ljubljana, Ljubljana, Slovenia

[18] Amer Univ Beirut Med Ctr, NK Basile Canc Inst Breast Ctr Excellence, Beirut, Lebanon

[19] Univ Sussex, Brighton & Sussex Med Sch, Falmer, England

[20] Europa Donna Malta, Breast Care Support Grp, Mtarfa, Malta

[21] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia

[22] BC Canc Agcy, Vancouver, BC, Canada

[23] UT MD Anderson Canc Ctr Houston, Dept Hlth Serv Res, Houston, TX USA

[24] UT MD Anderson Canc Ctr Houston, Dept Breast Med Oncol, Houston, TX USA

[25] IUC UPMC, AROME, Francilian Breast Intergrp, APHP Tenon, Paris, France

[26] European Inst Oncol, Program Breast Hlth, Milan, Italy

[27] Univ Munich, Brustzentrum, Munich, Denmark

[28] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia

[29] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10021 USA

[30] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel

[31] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[32] Europa Donna Cyprus, Nicosa, Cyprus

[33] AdvancedBC Org, New York, NY USA

[34] Univ Michigan, Sch Med, Ann Arbor, MI USA

[35] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA

[36] Europa Donna Sweden & Brostcanc Foreningarnas Rik, Sundbyberg, Sweden

[37] Oncol Inst Southern Switzerland, Bellinzona, Switzerland

[38] Breast Unit Southern Switzerland, Bellinzona, Switzerland

[39] Dana Farber Canc Inst, Div Womens Canc, Dept Med Oncol, Boston, MA 02115 USA

[40] Ctr Comprehens Canc, Jean Perrin Ctr, Clermont Ferrand, France

[41] Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium

[42] UCSF, Breast Oncol Program, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[43] Indiana Univ Med CTR, Indianapolis, IN USA

[44] Univ Halle Wittenberg, Dept Gynaecol, D-06108 Halle, Germany

[45] UCSF, Breast Oncol Program, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[46] Sandton Oncol Ctr, Johannesburg, South Africa

[47] Clin Grangettes, Dept Radiotherapy, Geneva, Switzerland

[48] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China

[49] Peking Union Med Coll, Beijing 100021, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2014年 / 25卷 / 10期

关键词：

PHASE-III TRIAL; ISOLATED LOCOREGIONAL RECURRENCE; EVEROLIMUS PLUS EXEMESTANE; MIDDLE-INCOME COUNTRIES; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; PRIMARY TUMOR; DOUBLE-BLIND; PATIENT NAVIGATION; 1ST-LINE THERAPY;

D O I：

10.1093/annonc/mdu385

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：1871 / 1888

页数：18

共 131 条

[1]

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial [J].

Aebi, Stefan ;

Gelber, Shari ;

Anderson, Stewart J. ;

Lang, Istvan ;

Robidoux, Andre ;

Martin, Miguel ;

Nortier, Johan W. R. ;

Paterson, Alexander H. G. ;

Rimawi, Mothaffar F. ;

Canada, Jose Manuel Baena ;

Thuerlimann, Beat ;

Murray, Elizabeth ;

Mamounas, Eleftherios P. ;

Geyer, Charles E., Jr. ;

Price, Karen N. ;

Coates, Alan S. ;

Gelber, Richard D. ;

Rastogi, Priya ;

Wolmark, Norman ;

Wapnir, Irene L. .

LANCET ONCOLOGY, 2014, 15 (02) :156-163

[2]

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study [J].

Alba, E. ;

Chacon, J. I. ;

Lluch, A. ;

Anton, A. ;

Estevez, L. ;

Cirauqui, B. ;

Carrasco, E. ;

Calvo, L. ;

Segui, M. A. ;

Ribelles, N. ;

Alvarez, R. ;

Sanchez-Munoz, A. ;

Sanchez, R. ;

Lopez Garcia-Asenjo, J. A. ;

Rodriguez-Martin, C. ;

Escudero, M. J. ;

Albanell, J. .

BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (02) :487-493

[3]

Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies [J].

Amir, Eitan ;

Clemons, Mark ;

Purdie, Colin A. ;

Miller, Naomi ;

Quinlan, Phil ;

Geddie, William ;

Coleman, Robert E. ;

Freedman, Orit C. ;

Jordan, Lee B. ;

Thompson, Alastair M. .

CANCER TREATMENT REVIEWS, 2012, 38 (06) :708-714

[4]

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The HERNATA Study [J].

Andersson, Michael ;

Lidbrink, Elisabeth ;

Bjerre, Karsten ;

Wist, Erik ;

Enevoldsen, Kristin ;

Jensen, Anders B. ;

Karlsson, Per ;

Tange, Ulla B. ;

Sorensen, Peter G. ;

Moller, Susanne ;

Bergh, Jonas ;

Langkjer, Sven T. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (03) :264-271

[5]

Breast cancer with synchronous metastases: Trends in survival during a 14-year period [J].

Andre, F ;

Slimane, K ;

Bachelot, T ;

Dunant, A ;

Namer, M ;

Barrelier, A ;

Kabbaj, O ;

Spano, JP ;

Marsiglia, H ;

Rouzier, R ;

Delaloge, S ;

Spielmann, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3302-3308

[6]

[Anonymous], J NATL CANC I

[7]

[Anonymous], J CLIN ONCOL

[8]

[Anonymous], BMJ SUPPORT PALLI S1

[9]

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study [J].

Bachelot, Thomas ;

Bourgier, Celine ;

Cropet, Claire ;

Ray-Coquard, Isabelle ;

Ferrero, Jean-Marc ;

Freyer, Gilles ;

Abadie-Lacourtoisie, Sophie ;

Eymard, Jean-Christophe ;

Debled, Marc ;

Spaeth, Dominique ;

Legouffe, Eric ;

Allouache, Djelila ;

El Kouri, Claude ;

Pujade-Lauraine, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) :2718-2724

[10]

Surgical removal of primary tumor and axillary lymph nodes in women with metastatic breast cancer at first presentation: A randomized controlled trial [J].

Badwe, R. ;

Parmar, V. ;

Hawaldar, R. ;

Nair, N. ;

Kaushik, R. ;

Siddique, S. ;

Navale, A. ;

Budrukkar, A. ;

Mittra, I. ;

Gupta, S. .

CANCER RESEARCH, 2013, 73

← 1 2 3 4 5 6 7 8 9 10 →